CytoDyn (CYDY) Shares Outstanding (Entity) (2010 - 2026)
CytoDyn's Shares Outstanding (Entity) came in at 1.37 billion for fiscal Q4 2026 (quarter ended May 31, 2026), up 10.0% from 1.25 billion a year earlier and up 1.1% from the prior quarter.
Powered by 
Analysis
CytoDyn (CYDY) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Going back to fiscal Q1 2011, CytoDyn's Shares Outstanding (Entity) data covers 64 quarters.
- Shares Outstanding (Entity) has increased in each of the last 15 fiscal years, with a five-year compound annual growth rate of 17.0% (FY2021 to FY2026).
- Going back by fiscal year, Shares Outstanding (Entity) was 1.25 billion in FY2025 (+18.0%), 1.06 billion in FY2024 (+15.2%), 918.61 million in FY2023 (+27.7%) and 719.59 million in FY2022 (+15.0%).
- The fiscal Q4 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to fiscal Q1 2011.
- Year-over-year, Shares Outstanding (Entity) has increased for 60 consecutive quarters, with growth averaging 15.8% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 3.0% (fiscal Q1 2026) to 31.0% (fiscal Q1 2025).
- Business Quant data shows CYDY's Shares Outstanding (Entity) at 1.36 billion (Q3 2026), 1.27 billion (Q2 2026) and 1.26 billion (Q1 2026) in the three fiscal quarters before Q4 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | CytoDyn | 274.70 Mn | 274.70 Mn | - | 1.37 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 1.37 Bn |
| Feb 28, 2026 | 1.36 Bn |
| Nov 30, 2025 | 1.27 Bn |
| Aug 31, 2025 | 1.26 Bn |
| May 31, 2025 | 1.25 Bn |
| Feb 28, 2025 | 1.23 Bn |
| Nov 30, 2024 | 1.22 Bn |
| Aug 31, 2024 | 1.22 Bn |
| May 31, 2024 | 1.06 Bn |
| Feb 29, 2024 | 989.93 Mn |
| Nov 30, 2023 | 971.29 Mn |
| Aug 31, 2023 | 930.96 Mn |
| May 31, 2023 | 918.61 Mn |
| Feb 28, 2023 | 836.59 Mn |
| Nov 30, 2022 | 824.84 Mn |
| Aug 31, 2022 | 812.26 Mn |
| May 31, 2022 | 719.59 Mn |
| Feb 28, 2022 | 713.29 Mn |
| Nov 30, 2021 | 685.42 Mn |
| Aug 31, 2021 | 643.68 Mn |
API Access
CytoDyn Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();